Saul,
LYC has never stated that they only get the Chinese domestic prices for their RE products. Basically because the FOB has usually been better and their price is related to LT contracts which remain "commercial in confidence"!
Shrouded in the uncertainties of LYC's reports IMO its a "long bow" to automatically assume because of the increased taxes in China that LYC will benefit, because LYC do not sell most of their product into China and never have!
However I do agree increased real price margins for REE generally will effect LYCs profit performance eventually, even if increased local taxes don't. When real improvement happens we should see the price increase in FOB as well as domestic, not just the one that plots the tax changes in China.
Until LYC actually release either a definitive statement saying they are achieving better prices and margins for their product then IMO your reasoning is nothing more than pure speculation or wishful thinking IMO. Even if it may eventually come true.
- Forums
- ASX - By Stock
- LYC
- Confidence growing
LYC
lynas rare earths limited
Add to My Watchlist
0.54%
!
$8.39

Confidence growing, page-116
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.39 |
Change
0.045(0.54%) |
Mkt cap ! $7.801B |
Open | High | Low | Value | Volume |
$8.31 | $8.44 | $8.30 | $3.007M | 359.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 10588 | $8.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.39 | 1191 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 291 | 8.410 |
8 | 8533 | 8.400 |
9 | 5460 | 8.390 |
10 | 9480 | 8.380 |
9 | 11852 | 8.370 |
Price($) | Vol. | No. |
---|---|---|
8.420 | 228 | 3 |
8.430 | 4924 | 8 |
8.440 | 7351 | 9 |
8.450 | 7931 | 8 |
8.460 | 16299 | 8 |
Last trade - 10.13am 03/07/2025 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online